[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-368939-105":59,"doc-detail-368939-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","hypermethylated-usp44-deubiquitinates-senp2-a-critical-mechanism-in-esophageal-cancer-progression-and-a-new-target-for-intervention","Hypermethylated USP44 deubiquitinates - SENP2: a critical mechanism in esophageal cancer progression and a new target for intervention","","Ubiquitin-specific proteases (USPs) are central to cancer development, and this study investigates how USP44 contributes to esophageal squamous cell carcinoma (ESCC). Promoter DNA methylation and USP44 expression were quantified in ESCC tissues and cell lines using pyrosequencing, RT-qPCR, and Western blot. Mechanistic links between USP44 and SENP2 were assessed with LC-MS/MS, Co-IP, CHX tracking, and ubiquitination analyses, complemented by functional in vitro and in vivo experiments. Clinical relevance was validated in 182 ESCC cases using IHC, Kaplan–Meier survival, Cox regression, and nomogram modeling.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/hypermethylated-usp44-deubiquitinates-senp2-a-critical-mechanism-in-esophageal-cancer-progression-and-a-new-target-for-intervention/368939/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/hypermethylated-usp44-deubiquitinates-senp2-a-critical-mechanism-in-esophageal-cancer-progression-and-a-new-target-for-intervention/368939.png","ImageObject",300,407,{"name":92,"@type":93},"awa","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-29","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":39},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What was the main research aim regarding USP44 and ESCC?","Question",{"text":112,"@type":113},"The study aimed to elucidate pathogenic molecular mechanisms and determine the clinical significance of USP44 in ESCC, focusing on its relation to SENP2 during disease progression.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers measure promoter methylation and USP44 expression?",{"text":117,"@type":113},"Promoter DNA methylation level and USP44 expression were detected in ESCC tissues and cell lines using pyrosequencing, RT-qPCR, and Western blot.",{"name":119,"@type":110,"acceptedAnswer":120},"What mechanism did the study propose for how USP44 affects ESCC progression?",{"text":121,"@type":113},"USP44 interacts with and stabilizes SENP2 through deubiquitination, thereby inhibiting ESCC progression; SENP2 knockdown reduced USP44’s inhibitory effects on migration and invasion.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},368939,1790789883,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":39,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},3985747858093,"https://ap-avatar.wpscdn.com/davatar_3d24733baf745e90a7e4bdd5f77d97b2","Wu et al. Clinical Epigenetics (2025) 17:191 [https://doi.org/10.1186/s13148-025-01958-1](https://doi.org/10.1186/s13148-025-01958-1)  \nClinical Epigenetics  \n RESEARCH Open Access  \nHypermethylated USP44 deubiquitinates   SENP2: a critical mechanism in esophageal cancer progression and a new target for intervention  \nHaibo Wu1,2†, Xinke Zhang1,2†, Zhengyi Zhou1,2†, Keming Chen1, Jierong Chen1, Chao Ma1, Jinling Duan 1,2, Yingqing Li2* and Jiewei Chen1,2*  \nAbstract  \nBackground Ubiquitin-specific proteases (USPs) play a critical role in the development of various cancers. The study aimed to elucidated the pathogenic molecular mechanisms and analyze its clinical significance in esophageal squamous cell carcinoma (ESCC) .  \nMethods Pyrosequencing, RT-qPCR and Western blot were used to detect the promoter DNA methylation  \nlevel and expression of USP44 in ESCC tissues and cell lines, and the significance of USP44/SENP2 in the progression of ESCC was evaluated by in vitro and in vivo experiments. The regulatory mechanism of USP44  \non SENP2 was explored by liquid chromatography-mass spectrometry, co-immunoprecipitation (Co-IP) com  \nbined with cycloheximide (CHX) tracking assay and ubiquitination analysis. Finally, 182 ESCC tissues were stained with immunohistochemistry (IHC), and the correlation between USP44 and prognosis was evaluated by Kaplan–Meier survival analysis, Cox regression and Nomogram model.  \nResults In ESCC tumor tissues and cell lines, USP44 is frequently hypermethylated and downregulated. Overexpression of USP44 significantly inhibits ESCC cell invasion and metastasis both in vitro and in vivo. Mechanistically, USP44 interacts with and stabilizes ubiquitin-like modifier (SUMO)-specific peptidase 2 (SENP2) through deubiquitination, thereby inhibiting the progression of ESCC. Knockdown of SENP2 reduced the inhibitory effect of USP44 on ESCC cell migration and invasion. Clinically, low expression of USP44 indicates poor prognosis and is an independent prognostic factor in ESCC patients, as evidenced by Kaplan–Meier curve and cox regression analysis (HR = 0 . 345, 95% CI 0.227- 0. 524, p \u003C 0. 001) . We established a nomogram model with robust predictive power for the 1-, 3-, and 5-year survival of ESCC patients (AUC = 0 . 849) .  \nConclusion USP44-SENP2 axis is a pivotal factor in the progression of ESCC, and provides potential therapeutic targets for ESCC patients.  \nKeywords USP44, Methylation, SENP2, Esophageal cancer  \n†Haibo Wu, Xinke Zhang, Zhengyi Zhou have contributed equally to this work.  \n*Correspondence: Yingqing Li[liyingq1@sysucc.org.cn](liyingq1@sysucc.org.cn)[ ](liyingq1@sysucc.org.cn)Jiewei Chen[chenjiew@sysucc.org.cn](chenjiew@sysucc.org.cn)  \n© The Author(s) 2025. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by-nc-nd/4.0/](http://creativecommons.org/licenses/by-nc-nd/4.0/.)[.](http://creativecommons.org/licenses/by-nc-nd/4.0/.)  \nIntroduction  \nESCC is the fourth most common cause of cancerrelated deaths globally, with a significant prevalence in Chin","cbCaigABekKpOZNm","https://ap.wps.com/l/cbCaigABekKpOZNm","pdf",3078783,15,"English","# Abstract\n# Background\n# Methods\n# Results\n# Conclusion\n# Introduction","[{\"question\":\"What was the main research aim regarding USP44 and ESCC?\",\"answer\":\"The study aimed to elucidate pathogenic molecular mechanisms and determine the clinical significance of USP44 in ESCC, focusing on its relation to SENP2 during disease progression.\"},{\"question\":\"How did the researchers measure promoter methylation and USP44 expression?\",\"answer\":\"Promoter DNA methylation level and USP44 expression were detected in ESCC tissues and cell lines using pyrosequencing, RT-qPCR, and Western blot.\"},{\"question\":\"What mechanism did the study propose for how USP44 affects ESCC progression?\",\"answer\":\"USP44 interacts with and stabilizes SENP2 through deubiquitination, thereby inhibiting ESCC progression; SENP2 knockdown reduced USP44’s inhibitory effects on migration and invasion.\"}]","Hypermethylated USP44 deubiquitinates - SENP2: a critical mechanism in esophageal cancer progression and a new target for intervention | PDF",1790179629,38,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/dcd8fc18a1b4a59a4d3a929e650716d8.webp",983,1305,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/8ef7a1ad29f275363b263a6b5313dc21.webp",982,1304,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/6477fb1f2f753fc9b8743047523c8b3c.webp",981,1303,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d2d9c82ff8e78c13eb53dcefe1bb3b4b.webp",980,1301]